Related Experiment Video
Updated: Jul 5, 2026
10:00
Induction and Analysis of Oxidative Stress in Sleeping Beauty Transposon-Transfected Human Retinal Pigment Epithelial Cells
Published on: December 11, 2020
Erythropoietin and oxidative stress
Kenneth Maiese1, Zhao Zhong Chong, Jinling Hou
1Division of Cellular and Molecular Cerebral Ischemia, Wayne State University School of Medicine, Detroit, Michigan 48201, USA. aa2088@wayne.edu
Current Neurovascular Research
|May 14, 2008
Summary
Erythropoietin shows potential for treating oxidative stress-related diseases like heart attack and diabetes. Further research is needed to ensure its safe and effective clinical use by understanding its complex signaling pathways.
Area of Science:
- Biochemistry
- Cellular Biology
- Pharmacology
Background:
- Oxidative stress accelerates aging and contributes to diseases like dementia and diabetes.
- Current treatments for oxidative stress-related disorders are limited, necessitating novel therapeutic strategies.
Purpose of the Study:
- To explore the potential of erythropoietin (EPO) as a therapeutic agent for diseases linked to oxidative stress.
- To investigate the molecular mechanisms by which EPO modulates cellular oxidative stress.
Main Methods:
- Review of existing literature on erythropoietin's role in cellular signaling pathways.
- Analysis of EPO's involvement in signal transduction pathways including JAK2, Akt, STAT, Wnt, FOXO, caspases, and NF-κB.
Main Results:
- Erythropoietin modulates multiple critical signaling pathways involved in cellular oxidative stress.
- EPO demonstrates potential therapeutic benefits in conditions such as cardiac ischemia, neurodegeneration, and diabetes.
Conclusions:
- Erythropoietin holds promise for treating various diseases by mitigating oxidative stress.
- Further investigation into EPO's complex signaling pathways is crucial for safe and effective clinical application.
Related Concept Videos
01:24Factors Affecting Erythropoiesis
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
01:14Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
01:14Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
01:28Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...